Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Total Revenue of $2.04 million for fiscal year 2025.
Dianthus Therapeutics, Inc. /DE/ Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.04M | -67.3% |
| 2024 | $6.24M | +120.6% |
| 2023 | $2.83M | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $396.0K | -81.8% | +105.2% |
| June 30, 2025 | $193.0K | -89.6% | -83.4% |
| March 31, 2025 | $1.16M | +33.1% | -46.5% |
| September 30, 2024 | $2.17M | +135.1% | +16.6% |
| June 30, 2024 | $1.86M | — | +113.2% |
| March 31, 2024 | $874.0K | — | -5.4% |
| September 30, 2023 | $924.0K | -21.2% | -21.2% |
| September 30, 2022 | $1.17M | — | — |
- Dianthus Therapeutics, Inc. /DE/ showed a decrease of -67.3% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Dianthus Therapeutics, Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: